Catabasis Pharmaceuticals Inc

NASDAQ:CATB  
2.09
-0.13 (-5.86%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Catabasis Pharmaceuticals Inc Stock, NASDAQ:CATB

100 High Street, 28th floor, Boston, Massachusetts 02110
United States of America
Phone: +1.617.349.1971
Number of Employees: 20
http://www.catabasis.com

Description

Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.